At a glance
- Originator Aventis
- Class Small molecules
- Mechanism of Action Cytokine inhibitors; T lymphocyte inhibitors; Tumour necrosis factor inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Septic shock; Transplant rejection